Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9444
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 0143-9444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Unit Label (Daptomycin Cc 500mg 2)
This text appears to be a detailed description of a medication, specifically a reconstitution instruction for 0.9% Sodium Chloride Injection, intended for intravenous infusion. The medication is provided in a single-dose vial and should be stored refrigerated at 2°C to 8°C. Any unused portion should be discarded. The information includes the dosage guidelines and specific instructions for storage.*
Carton (Daptomycin Cc 500mg 3)
This text appears to be information about a medication package containing Daptomycin for intravenous infusion. The package includes a single-dose vial of Daptomycin for injection and instructions for reconstitution and administration. It emphasizes visual inspection for particulate matter before administration and refrigeration storage requirements. The medication is provided in 500 mg/vial concentration and must be reconstituted with 10 mL of 0.9% Sodium Chloride Injection to obtain a final concentration of 50 mg/mL. The text also mentions product details like manufacturer and contact information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.